DENVER, CO -- February 25, 2022 -- InvestorsHub NewsWire --
American Cannabis Company, Inc. (OTCQB:
AMMJ) (ACC), a business-to-business cannabis consulting
solutions provider and licensed owner operator, is pleased to
announce a partnership with the Bubba Kush cannabis brand.
As part of this partnership, the Company will provide
extensive cultivation and consulting services to Bubba Kush,
and work closely with them to produce a line of Clean Green
Certified® cannabis. In addition, ACC will produce, package, sell
and distribute the Bubba Kush brand across Colorado.
“I am truly excited to work with the Bubba Kush brands and
support such a long-standing cannabis strain that has been a staple
in gardens for over 25 years. Our goal is to build on our
relationship with the Bubba Kush brand and expand into new markets
with them,” said Ellis Smith, co-founder and CEO of American
Cannabis Company.
This partnership also gives ACC the opportunity to offer
top-tier, organically based products at their Naturaleaf retail dispensaries, located in
the Colorado Springs area.
“We see this as a partnership that will allow us to not only
have a top-notch grow partner in the medical market of Colorado,
but also to pursue other collaborations as a team throughout the
legal cannabis industry,” said Reggie Harris, CEO and co-founder
of BK Brand Wellness, LLC. “We are very
careful with whom we will align our brand and grow alongside. Ellis
and his team really embrace the journey of bringing legacy genetics
to the current marketplace while looking for new innovations in
this fast-changing industry. We believe this provides a great
complement to the Bubba Kush core values and objectives.”
Ultimately, this partnership is a true win for the conscious
cannabis consumer in Colorado. Each year, there is a growing number
of individuals who prefer to consume high quality, clean green
cannabis products which are both better for the environment and
provide a more enjoyable smoking experience.
About American Cannabis Company, Inc.
American Cannabis Company,
Inc. offers clean green solutions to existing and aspiring
participants in the cannabis and hemp industries. They utilize
their industry expertise to provide business planning and market
assessment services, assist state licensing procurement, and create
business infrastructure operational best practices. This medically
licensed entity consists of three retail dispensaries, one
commercial cultivation facility, and one non-volatile extraction
operation. American Cannabis Company has also
developed SoHum Living Soils®, a winner of the High
Times S.T.A.S.H. Award for “Best Potting Mix.” SoHum Living Soils®
products are also OMRI Listed® and Clean Green Certified®.
For more information about American Cannabis Company, please
visit:
www.theacclife.com
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com
www.thenaturaleaf.com
Video Links:
https://americancannabisconsulting.com/resources/video/ (ACC
Site)
https://www.youtube.com/watch?v=XoIcopO2yE8&t (SoHum
Living Soils®)
ACC Contact:
IR@americancannabisconsulting.com
303-974-4770
Forward-Looking Statements
This news release contains "forward-looking statements," which
are not purely historical and may include any statements regarding
beliefs, plans, expectations or intentions regarding the future.
Such forward-looking statements include, among other things, the
development, costs and results of new business opportunities and
words such as "anticipate", "seek", intend", "believe", "estimate",
"expect", "project", "plan". These or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Actual results could
differ from those projected in any forward-looking statements due
to numerous factors. Such factors include, among others, the
inherent uncertainties associated with new projects, the future
U.S. and global economies, the impact of competition, and the
Company's reliance on existing regulations regarding the use and
development of cannabis-based drugs. These forward-looking
statements are made as of the date of this news release, and we
assume no obligation to update the forward-looking statements or to
update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe
that any beliefs, plans, expectations and intentions contained in
this press release are reasonable, there can be no assurance that
any such beliefs, plans, expectations or intentions will prove to
be accurate. Investors should consult all of the information set
forth herein and should also refer to the risk factors disclosure
outlined in our annual report on Form 10-K for the most recent
fiscal year, our quarterly reports on Form 10-Q and other periodic
reports filed from time to time with the Securities and Exchange
Commission. For more information, please visit www.sec.gov.
Cannabis Remains an Illegal Schedule 1 Drug Under
Federal Law
Thirty-five states, including Colorado, the District of Columbia
and four U.S. Territories currently have laws broadly legalizing
cannabis in some form for either medicinal and/or recreational use
governed by state specific laws and regulations. Although legalized
in some states, cannabis is a “Schedule 1” drug under the
Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is illegal
under federal law. Cannabis and its derivatives are viewed as being
highly addictive and having no medical value. The United States
Drug Enforcement Agency enforces the Controlled Substances Act, and
persons violating it are subject to federal criminal
prosecution.
As a result of the November 2020 federal elections, and the
election of Joseph R. Biden as president, it is expected that the
federal government will move to amend parts of the CSA and
de-schedule cannabis as a Schedule 1 drug.
In late January 2021, Senate Majority Leader Chuck Schumer said
lawmakers are in the process of merging various cannabis bills,
including his own legalization legislation. He is working to enact
reform in this Congressional session. This would include the
Marijuana Freedom and Opportunity Act, that would federally
de-schedule cannabis, reinvest tax revenue into communities most
affected by the drug war, and fund efforts to expunge prior
cannabis records. It is likely that the Marijuana Opportunity,
Reinvestment, and Expungement (MORE) Act would be incorporated.
Other federal legislation under review for possible submission
includes the SAFE Banking Act (or Secure and Fair Enforcement Act),
a bill that would allow cannabis companies to access the
federally-insured banking system and capital markets without the
risk of federal enforcement action, and the Strengthening the Tenth
Amendment Through Entrusting States Act (or STATES Act), a bill
that seeks protections for businesses and individuals in states
that have legalized and comply with state laws).
Notably with respect to our business, on November 1, 2019,
Colorado Bill HB-19-1090, was passed and made effective. This law
allows publicly traded corporations to apply for and qualify for
the ownership of Colorado cannabis licenses. Other states that have
legalized cannabis for recreational and/or medicinal use restrict
public companies from owning interests in state cannabis licenses
altogether, or have enacted regulations which make it difficult for
corporations to comply with application requirements, including all
shareholders submitting to and passing background checks.
On September 18, 2020, Colorado’s Marijuana Enforcement Division
(MED), approved the Company’s application for suitability,
establishing the Company as one of the few publicly traded
companies authorized to acquire and operate various cannabis
licenses throughout Colorado, in both the recreational and medical
markets.
Investor Relations
303-974-4770
IR@americancannabisconsulting.com
American Cannabis (CE) (USOTC:AMMJ)
Historical Stock Chart
From Oct 2024 to Nov 2024
American Cannabis (CE) (USOTC:AMMJ)
Historical Stock Chart
From Nov 2023 to Nov 2024
